Managed Care Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
U.S. FDA grants marketing clearance for Zoll's defibrillator with Real CPR Help technology
February 12th, 2007
Zoll Medical Corporation (ZOLL), a manufacturer of resuscitation devices and related software, announced that it received clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Zoll E series with Real CPR Help technology. Zoll's Real CPR Help allows rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions. With this clearance, the E series becomes Zoll's first advanced pre-hospital device to provide this instantaneous feedback. All cardiac arrest victims need immediate and effective CPR. Furthermore, less than half of these victims require defibrillation initially since...
Source: Managed Care Weekly Digest (2007-02-12)
|
